MARKSANS PHARMA (India) Today

Equity ratings for MARKSANS PHARMA LT are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of August 2021 and ending today, the 29th of November 2021. Click here to learn more.
MARKSANS PHARMA LT cannot be verified against its exchange. Apparently, MARKSANS PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

MARKSANS PHARMA Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. MARKSANS PHARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding MARKSANS PHARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
MARKSANS PHARMA LT is not yet fully synchronised with the market data
MARKSANS PHARMA LT has some characteristics of a very speculative penny stock
Legal NameMARKSANS PHARMA LT
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of MARKSANS PHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
MARKSANS PHARMA LT (MARKSANS) is traded on National Stock Exchange of India in India and employs 596 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 6.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MARKSANS PHARMA's market, we take the total number of its shares issued and multiply it by MARKSANS PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. MARKSANS PHARMA LT operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 409.31 M outstanding shares.
Check MARKSANS PHARMA Probability Of Bankruptcy

MARKSANS Stock Against Markets

Picking the right benchmark for MARKSANS PHARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in MARKSANS PHARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for MARKSANS PHARMA is critical whether you are bullish or bearish towards MARKSANS PHARMA LT at a given time.
MARKSANS PHARMA LT cannot be verified against its exchange. Apparently, MARKSANS PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MARKSANS PHARMA stock to make a market-neutral strategy. Peer analysis of MARKSANS PHARMA could also be used in its relative valuation, which is a method of valuing MARKSANS PHARMA by comparing valuation metrics with similar companies.
Check out Stocks Correlation. Note that the MARKSANS PHARMA LT information on this page should be used as a complementary analysis to other MARKSANS PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Other Tools for MARKSANS Stock

When running MARKSANS PHARMA LT price analysis, check to measure MARKSANS PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MARKSANS PHARMA is operating at the current time. Most of MARKSANS PHARMA's value examination focuses on studying past and present price action to predict the probability of MARKSANS PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move MARKSANS PHARMA's price. Additionally, you may evaluate how the addition of MARKSANS PHARMA to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go